JAMA Medical News

November 2023 Medical News Summary

11.30.2023 - By JAMA NetworkPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Why Physicians Don’t Deprescribe Medicines; What to Know About Wegovy’s Rare but Serious Adverse Effects; What to Know About Zepbound, the Newest Antiobesity Drug Related Content: As Semaglutide’s Popularity Soars, Rare but Serious Adverse Effects Are Emerging FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management Deciding When It’s Better to Deprescribe Medicines Than to Continue Them

More episodes from JAMA Medical News